CATALYSTS: *** Collaborative project with Sanofi Pasteur(vaccine division of French Drugmaker Sanofi,NYSE:SNY) will come into conclusion before end of 2018. *** Mymetics is leading a consortium of 4 european companies including giant CMO Catalent, NYSE:CTLT to develop a solid state thermostable cold chain independent vaccines (MACIVIVA)using Mymetics' HIV-1 vaccine since April 2015 and will come into conclusion before end of 2018.